Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026)
Earth Science Tech's (ETST) quarterly Non Operating Investment Income came in at -$695051.0 in Q1 2026, down 653.61% YoY from $125549.0 in Q1 2025, and down 13.25% on a QoQ basis from -$613741.0 in Q4 2025.
Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 3 years of Non Operating Investment Income data on file, last reported at -$695051.0 in Q1 2026.
- Quarterly Non Operating Investment Income fell 653.61% year-over-year to -$695051.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (changed N/A YoY) and the FY2026 annual result came in at -$957118.0, down 418.87% from the prior year.
- Non Operating Investment Income eased to -$695051.0 in Q1 2026, from -$613741.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $145558.0 in Q3 2025 to a low of -$695051.0 in Q1 2026.
- A 3-year average of -$192229.3 and a median of -$57845.5 in 2024 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2025 — Non Operating Investment Income plunged 211.11% — and 2026, when it slumped 653.61%.
- Tracing ETST's Non Operating Investment Income over 3 years: stood at -$197277.0 in 2024, then sank by 211.11% to -$613741.0 in 2025, then slipped by 13.25% to -$695051.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$695051.0 (Q1 2026), -$613741.0 (Q4 2025), and $145558.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Earth Science Tech | 31.63 Mn | 28.84 Mn | 6.28 Mn | 365,537.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 365,537.00 |
| Jun 30, 2026 | 365,537.00 |
| Mar 31, 2026 | -695,051.00 |
| Mar 31, 2026 | -695,051.00 |
| Dec 31, 2025 | -613,741.00 |
| Dec 31, 2025 | -613,741.00 |
| Sep 30, 2025 | 145,558.00 |
| Sep 30, 2025 | 145,558.00 |
| Jun 30, 2025 | 81,586.00 |
| Jun 30, 2025 | 81,586.00 |
| Mar 31, 2025 | 125,549.00 |
| Mar 31, 2025 | 125,549.00 |
| Dec 31, 2024 | -197,277.00 |
| Dec 31, 2024 | -197,277.00 |